NCT03919292 2026-04-21
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT06199557 2025-06-29
HUVAMER
Haukeland University Hospital
Phase 1/2 Recruiting
NCT04729543 2023-12-04
MC2TCR
Erasmus Medical Center
Phase 1/2 Recruiting
NCT01898104 2023-03-24
V-shoRT-R3
National Cancer Institute, Naples
Phase 1/2 Unknown
NCT00075010 2018-11-15
Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01622439 2018-03-12
VALFRID
Lund University Hospital
Phase 1/2 Completed
NCT00175812 2015-06-24
Differentiation Induction in Acute Myelogenous Leukemia
University of Bergen
Phase 1/2 Completed
NCT00995332 2015-06-24
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
University of Bergen
Phase 1/2 Completed
NCT01369368 2015-06-24
Treatment of Acute Leukemia Relapse After Allotransplantation
University of Bergen
Phase 1/2 Unknown
NCT00358319 2013-11-25
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated
NCT01295593 2012-06-07
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Unknown
NCT01203735 2011-03-29
Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer
Soroka University Medical Center
Phase 1/2 Unknown